Oric Pharmaceuticals Inc (ORIC)

Oric Pharmaceuticals Inc (ORIC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day -3.4%, 1 week +6.6%, 1 year +6.0%.

ORIC Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics designed to overcome mechanisms of therapeutic resistance in cancer.

Groups ORIC belongs to

• Clinical Stage Biotech
• Oncology
• Biotechnology
• Clinical Stage
• Biopharmaceutical
• Healthcare
• Pharmaceuticals
• Cancer Therapeutics
• Drug Discovery
• R&D

ORIC financial model: income statement, cash flow and balance sheet